EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update

Neevashini Chengebroyen, Anmol Seelan, Kamal Yoonus Thajudeen, Saad Ali Alshehri, Aritra Biswas, Israrahmed Adur, Vino Sundararajan, Sajitha Lulu Sudhakaran, Harpreet Singh

Frontiers in Pharmacology · 23.07.2025 · 16

DOI: 10.3389/fphar.2025.1630475 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.07.2025. Verfasst von Neevashini Chengebroyen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders, marked by the gradual degeneration and dysfunction of neurons, pose substantial clinical challenges due to the paucity of effective therapeutic strategies and the intricate and multifactorial nature of their underlying pathophysiology. On the other hand nanotechnology, Recent advancements in nanotechnology-driven interventions have significantly augmented the therapeutic potential of stem-cell therapies for the treatment of these complex conditions. Critical limitations in current therapeutic approaches have been highlighted, while potential future directions for their therapy have been outlined. Stem cell types—embryonic, induced pluripotent, and adult neural stem cells—are categorized, with a focus on their unique biological properties and therapeutic potentials in addressing neurodegenerative conditions. The role of nanomaterials in augmenting stem cell generation, scaffold fabrication, and targeted delivery mechanisms is examined, with particular emphasis on the capacity of nanotechnology to enhance regenerative processes and neuroprotective interventions. Nanomaterial-conjugated stem cell therapies are specifically addressed, focusing on their applications in neuronal recovery and treatment monitoring. Challenges associated with stem cell therapies, including ethical considerations, immunogenicity, and the necessity for stringent clinical validation, are critically examined. The integration of nanomedicine with stem cell research is proposed as a promising strategy to overcome these challenges and facilitate the development of novel therapeutic approaches. A comprehensive framework for future research is proposed, focusing on the synergistic integration of nanotechnological advancements with stem cell therapies to improve clinical outcomes and drive innovation in the treatment of neurodegenerative disorders. By integrating existing knowledge and highlighting critical gaps, this review seeks to foster continued research and interdisciplinary collaboration, accelerating progress in this rapidly evolving field.

Schlagwörter

Stichwörter der Autor:innen

nanomaterial-conjugated regenerative therapynanomedicinenanotechnologyneurodegenerative disordersneuroprotective-nanotechnology stem-cell therapyscaffold

Autor:innen und Institutionen

  • Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia.
  • Department of Biological Sciences, Sunandan Divatia School of Science, Narsee Monjee Institute of Management Studies (NMIMS), Mumbai, India.
  • Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Department of Biotechnology, UNESCO Regional Centre for Biotechnology, Government of India, Faridabad, Haryana, India.
  • Manipal Institute of Regenerative Medicine (MIRM), Manipal Academy of Higher Education (MAHE), Bangalore, Karnataka, India.
  • Integrative Multiomics Lab, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Zitieren

APA

Chengebroyen, N., Seelan, A., Yoonus Thajudeen, K., Alshehri, S. A., Biswas, A., Adur, I., Sundararajan, V., Lulu Sudhakaran, S., & Singh, H. (2025). Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1630475

Vancouver

Chengebroyen N, Seelan A, Yoonus Thajudeen K, Alshehri SA, Biswas A, Adur I, et al. Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1630475

BibTeX
@article{Chengebroyen2025,
  author = {Chengebroyen, Neevashini and Seelan, Anmol and Yoonus Thajudeen, Kamal and Alshehri, Saad Ali and Biswas, Aritra and Adur, Israrahmed and Sundararajan, Vino and Lulu Sudhakaran, Sajitha and Singh, Harpreet},
  title = {Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1630475}
}
Kostenlos starten →